Sickle Cell Disease Comprehensive Care Act
Summary
Sickle Cell Disease Comprehensive Care Act This bill establishes and provides funds for a demonstration project for state Medicaid programs to improve outpatient care for individuals with sickle cell disease, with a focus on young adults and pregnant women. The Centers for Medicare & Medicaid Services must award planning grants to at least 10 states and must select between 5 and 10 states to participate in the project. Participating states must provide specified services and support for individuals with sickle cell disease, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services. The bill provides a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for services provided through the project.
Bill status
in committee
1 of 4 stages cleared
Introduction
Dec 2021
Committee Review
Floor Vote
President
Introduced Dec 9, 2021
Last action Dec 10, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Dec 10, 2021
Committee
Referred to the Subcommittee on Health.
lower
Dec 9, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
Dec 9, 2021
Introduced
Introduced in House
lower
1 primary · 17 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Danny K. Davis
DDemocratic
Co
Al Lawson, Jr.
DDemocratic
Co
Alma S. Adams
DDemocratic
Co
André Carson
DDemocratic
Co
Antonio Delgado
DDemocratic
Co
Barbara Lee
DDemocratic
Co
Bill Foster
DDemocratic
Co
Bobby L. Rush
DDemocratic
Co
Eleanor Holmes Norton
DDemocratic
Co
Gwen Moore
DDemocratic
Co
Karen Bass
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 6216
Scope: US
Hi! I can help you understand HR 6216. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline